![Leslie Sloan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Leslie Sloan served as the Chief Operating Officer at Spyre Therapeutics, Inc. from 2019 to 2023 and as the President & VP-Global R&D Project at Ipsen Bioscience, Inc. from 2012 to 2017.
Sloan earned a doctorate degree from Yale University in 1999 and an undergraduate degree from Southeastern Oklahoma State University in 1993.
Anciens postes connus de Leslie Sloan
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur des opérations | 05/01/2023 |
Ipsen Bioscience, Inc.
 Ipsen Bioscience, Inc. BiotechnologyHealth Technology Develops and wholesales drugs | President | 01/04/2017 |
Formation de Leslie Sloan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southeastern Oklahoma State University
 Southeastern Oklahoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Bioscience, Inc.
Ipsen Bioscience, Inc. BiotechnologyHealth Technology Develops and wholesales drugs | Health Technology |
